About 6.5M results
Update on ADJUVANT BR.31 Phase III trial of Imfinzi in non-small …
Adjuvant durvalumab extends survival in small cell lung cancer
Imfinzi Improves Survival in Small Cell Lung Cancer - NCI
Durvalumab Consolidation Therapy Extends Survival in Limited …
Imfinzi is first and only immunotherapy to show survival benefit in ...
Interim ADRIATIC Results: Durvalumab Improves ... - ASCO Daily News
Overall Survival with Durvalumab after Chemoradiotherapy in …
Perioperative Durvalumab for Resectable Non–Small-Cell Lung …
Consolidation Therapy With Durvalumab for Limited-Stage SCLC
Durvalumab Significantly Improves Survival for Patients With …